Trial Profile
Dose finding study of lipegfilgrastim in patients with breast cancer receiving myelosuppressive therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Lipegfilgrastim (Primary) ; Pegfilgrastim
- Indications Neutropenia
- Focus Therapeutic Use
- 15 Jul 2015 New trial record